Your browser doesn't support javascript.
Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.
Chaidos, Aristeidis; Katsarou, Alexia; Mustafa, Chira; Milojkovic, Dragana; Karadimitris, Anastasios.
  • Chaidos A; Centre for Haematology, Department of Immunology & Inflammation, Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College, London, UK.
  • Katsarou A; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Mustafa C; Centre for Haematology, Department of Immunology & Inflammation, Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College, London, UK.
  • Milojkovic D; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Karadimitris A; Centre for Haematology, Department of Immunology & Inflammation, Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College, London, UK.
Br J Haematol ; 190(1): e9-e11, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-1343824

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Interleukin-6 / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus / Multiple Myeloma / Neoplasm Proteins Type of study: Prognostic study Limits: Aged / Humans / Male / Middle aged Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16787

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Interleukin-6 / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus / Multiple Myeloma / Neoplasm Proteins Type of study: Prognostic study Limits: Aged / Humans / Male / Middle aged Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16787